Abstract
Transmitters, hormones, and most of the therapeutic drugs exert their biological functions by generating signals in target cells through interaction with a receptor molecule in the cellular membrane, cytosol, or even at the nucleus of the cell. Because receptors play such a crucial role in cell function, especially within the central nervous system (CNS), we need lab techniques to measure their expression and functionality. There are techniques to determine regulatory changes in receptor number (receptor density), subcellular distribution, anatomical distribution, the physiological function of the receptors, as well as the ligand affinity.
Here we describe a classic way of doing this by exposing cells or tissue membranes to radiolabeled molecules (radioligands) that bind selectively to receptors in the sample (receptor binding assay). The functional consequence of the receptor occupancy or level of G-protein activation could be measured by [ 35 S]GTPγS binding assay. This assay measures the binding of the non-hydrolyzable analogue [35S]GTPγS ([35S]guanosine-5′-O-(3-thio) triphosphate) to Gα subunits. [35S]GTPγS binding assays, also known as functional binding assays, are carried out in a similar way as radioligand (receptor) binding assays.
The above radiometric assays are useful to differentiate among agonist, antagonist, and inverse agonist activities, in addition to traditional pharmacological parameters of potency and efficacy, as well as receptor constitutive activity and agonist-specific G-protein-coupled signaling. Moreover, radioligand binding assays provide a powerful tool for screening drug candidates for many receptors in drug discovery research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yamamura HI, Enna SJ, Kuhar MJ (1990) Methods in neurotransmitter receptor analysis. Raven, Nueva York
Selley DE, Stark S, Sim LJ, Childers SR (1996) Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes. Life Sci 59:659–668
Harrison C, Traynor JR (2003) The 35S GTP-gamma-S binding assay: approaches and applications in pharmacology. Life Sci 74:489–508
Snyder SH, Bennett JP Jr (1976) Neurotransmitter receptors in the brain: biochemical identification. Annu Rev Physiol 38:153–175
Kenakin TP (1997) The pharmacologic analysis of drug receptor interaction, 3rd edn. Lippincott-Raven, New York
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for the characterization of ligand binding system. Anal Biochem 107:220–239
Strange PG (2010) Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors. Br J Pharmacol 161:1238–1249
Alexander SPH, Harmar AJ (eds) (2013) Concise guide to pharmacology 2013/14. Br J Pharmacol 170(8):1449–1458.
DeLapp NW (2004) The antibody-capture [(35)S]GTPgammaS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology. Trends Pharmacol Sci 25:400–401
Acknowledgments
This work was supported by Ministerio de Ciencia, SAF07-61862; Ministerio de Economia y Competitividad, SAF2011-25020; and Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Pilar-Cuéllar, F., Díaz, A., Garro-Martínez, E., Martín, A., Romero, B., Valdizán, E.M. (2016). Radioligand Binding Detection of Receptors in Brain Membranes. In: Luján, R., Ciruela, F. (eds) Receptor and Ion Channel Detection in the Brain. Neuromethods, vol 110. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3064-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3064-7_6
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3063-0
Online ISBN: 978-1-4939-3064-7
eBook Packages: Springer Protocols